Studies and Publications

• Proprietary Consilium Care Platform & App

CE-Mark Class I (MDD Class I)

Enables symptom progression tracking and CTCAE-based notifications to patients and oncologists.

• Clinical Trial: Patient-App Improves Daily Activity

Randomized trial in 140 breast cancer patients undergoing chemotherapy

📰 Published in JMIR 2016

🔗 PubMed: 27601354

• Collaboration with SAKK – Alpine Tumor Immunology Registry (TIR)

Symptom recording in 150 patients undergoing immunotherapy

📰 SAKK Trial Link

✔️ Accepted for publication in Current Oncology

(Topic: machine learning on ePROs to cluster symptoms by cancer type)

• Consilium App Improves ePRO Monitoring in Immunotherapy

Case report in lung cancer: shared reporting improves comfort and efficiency

📰 Case Reports in Oncology, 2020

🔗 PubMed: 32518544

• Clinical Trial: Patient-App Improves Symptom Recording

Digital symptom recording enhances patient-doctor interaction in 192 cancer patients

📰 JMIR Cancer, 2021

🔗 PubMed: 33729162

• Report on Medication Effectiveness in Personalized Medicine

Durable response and tolerability in breast cancer therapy

📰 Case Reports in Oncology, 2021

🔗 PubMed: 32518544

• Review: ePROs Improve Congruence of Patient- and Clinician-Reported Toxicity

Collaborative monitoring in 224 cancer patients

📰 JMIR, 2021

🔗 PubMed: 33729162

• Evaluation of the Positive Care Effect of the Digital Health App Consilium Care Oncology

Multicenter randomized controlled trial with 520 patients, 40 centers (Germany & Switzerland)

🧪 Ongoing trial

Ethics Approval: KEK-2022-D0021

• HER2-Biosimilar in Breast Cancer (OGIPRO Study)

Real-world ePRO observational trial – 80 patients, 8 centers

📰 Published in JMIR Cancer (2024)

🔗 Article

🔍 kofam Trial Registry

Ongoing Trials and Registries

• THC-CBD for Nausea, Emesis, Sleeplessness, Pain, Anxiety, Appetite Loss in Cancer Assessed via ePRO

Prospective randomized controlled study – 150 patients, 6 centers

Registry now maintained under Swiss sponsorship

🔗 FMH Medical Registry

• Efficiency of the “Medidux” Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)

Observational study on emergency-related symptom tracking and cost reduction

🔗 ClinicalTrials.gov: NCT06655337